Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Amdocs (DOX) Beats Q1 Earnings and Revenue Estimates

Published 02/01/2022, 05:25 AM
Updated 07/09/2023, 06:31 AM

Amdocs (NASDAQ:DOX) came out with quarterly earnings of $1.20 per share, beating the Zacks Consensus Estimate of $1.19 per share. This compares to earnings of $1.16 per share a year ago. These figures are adjusted for non-recurring items.

This quarterly report represents an earnings surprise of 0.84%. A quarter ago, it was expected that this provider of computer systems integration would post earnings of $1.18 per share when it actually produced earnings of $1.16, delivering a surprise of -1.69%.

Over the last four quarters, the company has surpassed consensus EPS estimates two times.

Amdocs, which belongs to the Zacks Computers - IT Services industry, posted revenues of $1.1 billion for the quarter ended December 2021, surpassing the Zacks Consensus Estimate by 0.40%. This compares to year-ago revenues of $1.09 billion. The company has topped consensus revenue estimates three times over the last four quarters.

The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.

Amdocs shares have added about 1.4% since the beginning of the year versus the S&P 500's decline of -5.3%.

What's Next for Amdocs?

While Amdocs has outperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?

There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.

Ahead of this earnings release, the estimate revisions trend for Amdocs: unfavorable. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #4 (Sell) for the stock. So, the shares are expected to underperform the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.

It will be interesting to see how estimates for the coming quarters and current fiscal year change in the days ahead. The current consensus EPS estimate is $1.29 on $1.12 billion in revenues for the coming quarter and $5.18 on $4.52 billion in revenues for the current fiscal year.

Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Computers - IT Services is currently in the top 37% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.

CoStar Group (NASDAQ:CSGP), another stock in the same industry, has yet to report results for the quarter ended December 2021. The results are expected to be released on February 22.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

This commercial real estate information and marketing provider is expected to post quarterly earnings of $0.29 per share in its upcoming report, which represents no change from the year-ago quarter. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days.

CoStar Group's revenues are expected to be $500.59 million, up 12.7% from the year-ago quarter.


7 Best Stocks for the Next 30 Days

Just released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers "Most Likely for Early Price Pops."

Since 1988, the full list has beaten the market more than 2X over with an average gain of +25.3% per year. So be sure to give these hand-picked 7 your immediate attention.

See them now >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Amdocs Limited (DOX): Free Stock Analysis Report

CoStar Group, Inc. (CSGP): Free Stock Analysis Report

To read this article on Zacks.com click here.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.